Anti-carcinogenic effect of a new analogue 4′-chloroflavanone from flavanone in human breast cancer cells

International Journal of Molecular Medicine

Volumn 25, Issue 2, 2010, Pages 293-298

  Choi, Eun Jeong ^a   Lee, Jae In ^a   Kim, Gun Hee ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Apoptosis, 4 chloroflavanone; Cell proliferation; Flavanone; Synthetic derivatives

Indexed keywords

4' CHLOROFLAVANONE; ANTINEOPLASTIC AGENT; CASPASE 3; CYTOCHROME C; FLAVANONE; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLINS; FEMALE; FLAVANONES; FLAVONOIDS; G1 PHASE; HUMANS;

EID: 73649140288     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000344     Document Type: Article

References (24)

1. Walle T: Absorption and metabolism of flavonoids. Free Radic Biol Med 36: 829-837, 2004.
2. Kim HP, Son KH, Chang HW and Kang SS: Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci 96: 229-245, 2004.
3. Kanadaswami C, Lee LT, Lee PP, et al: The antitumor activities of flavonoids. In Vivo 19: 895-909, 2005.
4. Cushnie TP and Lamb AJ: Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26: 343-356, 2005.
5. Pouget C, Lauthier F, Simon A, et al: Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. Bioorg Med Chem Lett 11: 3095-3097, 2001.
6. Lopez-Lazaro M: Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anticancer Agents 2: 691-714, 2002.
7. Choi EJ, Chee KM and Lee BH: Anti- and prooxidant effects of chronic quercetin administration in rats. Eur J Pharmacol 482: 281-285, 2003.
8. Choi EJ, Kim GD, Chee KM and Kim GH: Effects of hesperetin on vessel structure formation in mouse embryonic stem (mES) cells. Nutrition 22: 947-951, 2006.
9. Kris-Etherton PM, Lefevre M, Beecher GR, Gross MD, Keen CL and Etherton TD: Bioactive compounds in nutrition and health-research methodologies for establishing biological function: the antioxidant and anti-inflammatory effects of flavonoids on atherosclerosis. Annu Rev Nutr 24: 511-538, 2004.
10. Ameer B, Weintraub RA, Johnson JV, Yost RA and Rouseff RL: Flavanone absorption after naringin, hesperidin, and citrus administration. Clin Pharmacol Ther 60: 34-40, 1996.
11. Pelt JL, Downer WA, Schoborg RV and McIntosh CA: Flavanone 3-hydroxylase expression in Citrus paradisi and Petunia hybrida seedlings. Phytochemistry 34: 435-444, 2003.
12. Deep J, Singh RP, Agarwal C, Kroll DJ and Agawal R: Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res 60: 1053-1069, 2006.
13. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18: 629-643, 1998.
14. Bai F, Matsui T, Ohtani-Fujita N, Matsukawa Y, Ding Y and Sakai T: Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. FEBS Lett 437: 61-64, 1998.
15. May P and May E: Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18: 7621-7636, 1999.
16. Agarwal ML, Agarwal A, Taylor WR and Stark GR: p53 controls both the G2/ M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493-8497, 1995.
17. Park M, Chae HD, Yun J, et al: Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res 60: 542-545, 2000.
18. Lepik D, Jaks V, Kadaja L, Varv S and Maimets T: Electroporation and carrier DNA cause p53 activation, cell cycle arrest, and apoptosis. Anal Biochem 318: 52-59, 2003.
19. Parker MA, Anderson JK, Corliss DA, et al: Expression profile of an operationally-defined neural stem cell clone. Exp Neurol 194: 320-332, 2005.
20. Oakea SA, Lin SS and Bassik MC: The control of endoplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr Mol Med 6: 99-109, 2006.
21. Van Delft MF and Huang DC: How the Bcl-2 family of proteins interact to regulate apoptosis. Cell Res 16: 203-213, 2006.
22. Jiang X and Xang X: Cytochrome C-mediated apoptosis. Annu Rev Biochem 73: 87-106, 2004.
23. Porter AG and Janicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6: 99-104, 1999.
24. Abu-Qare AW and Abou-Donia MB: Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2'-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J Toxicol Environ Health B Crit Rev 4: 313-332, 2001.